Aspen Aerogels, Inc. (NYSE:ASPN) Receives $19.50 Consensus PT from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has received an average rating of “Moderate Buy” from the eleven brokerages that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, two have given a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $19.50.

ASPN has been the topic of several recent analyst reports. Barclays downgraded shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and upped their price objective for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Aspen Aerogels in a research note on Saturday, September 27th.

Insider Buying and Selling

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 4.30% of the company’s stock.

Institutional Investors Weigh In On Aspen Aerogels

A number of large investors have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC boosted its stake in Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after acquiring an additional 4,390 shares during the last quarter. SBI Securities Co. Ltd. boosted its stake in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after acquiring an additional 4,693 shares during the last quarter. Acadian Asset Management LLC bought a new position in Aspen Aerogels during the 1st quarter valued at $43,000. Finally, Banque Cantonale Vaudoise bought a new position in Aspen Aerogels during the 1st quarter valued at $45,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Trading Up 7.6%

Shares of Aspen Aerogels stock opened at $7.76 on Friday. Aspen Aerogels has a 52-week low of $4.16 and a 52-week high of $26.90. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The company’s 50-day simple moving average is $7.10 and its 200-day simple moving average is $6.44. The firm has a market cap of $638.70 million, a price-to-earnings ratio of -2.04 and a beta of 2.80.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. During the same period in the prior year, the business posted $0.21 earnings per share. The firm’s revenue for the quarter was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. As a group, equities research analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.